,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,,2018-12-26 16:35:04,2018-12-24,OMED,Gurney Austin,See Remarks,S - Sale,$0.60,-11117,66807,-14%,"-$6,669",,,,,OMED
1,,2018-10-11 19:00:18,2018-10-10,OMED,Stagg Robert,"SVP, Clinical R, D",S - Sale,$2.01,-927,40670,-2%,"-$1,863",,,,,OMED
2,,2018-10-11 18:59:07,2018-10-10,OMED,Li Yvonne,See Remarks,S - Sale,$2.02,-927,59734,-2%,"-$1,873",,,,,OMED
3,,2018-10-11 18:57:54,2018-10-10,OMED,Gurney Austin,See Remarks,S - Sale,$2.01,-1156,77924,-1%,"-$2,324",,,,,OMED
4,,2018-10-11 18:56:46,2018-10-10,OMED,Hager Alicia J.,"SVP, GC",S - Sale,$2.02,-1156,51754,-2%,"-$2,335",,,,,OMED
5,,2018-10-11 18:55:39,2018-10-10,OMED,Lewicki John A.,"Pres, CEO",S - Sale,$2.01,-1156,155354,-1%,"-$2,324",,,,,OMED
6,,2018-10-10 19:44:00,2018-10-09,OMED,Li Yvonne,See Remarks,S - Sale,$2.13,-1229,60661,-2%,"-$2,616",,,,,OMED
7,,2018-10-10 19:42:35,2018-10-09,OMED,Gurney Austin,See Remarks,S - Sale,$2.13,-1686,79080,-2%,"-$3,589",,,,,OMED
8,,2018-10-10 19:41:28,2018-10-09,OMED,Stagg Robert,"SVP, Clinical R, D",S - Sale,$2.13,-1686,41597,-4%,"-$3,589",,,,,OMED
9,,2018-10-10 19:40:23,2018-10-09,OMED,Lewicki John A.,"Pres, CEO",S - Sale,$2.13,-2296,156510,-1%,"-$4,888",,,,,OMED
10,,2018-10-10 19:38:53,2018-10-09,OMED,Hager Alicia J.,"SVP, GC",S - Sale,$2.13,-1686,52910,-3%,"-$3,589",,,,,OMED
11,,2018-04-26 18:14:16,2018-04-24,OMED,Li Yvonne,See Remarks,S - Sale,$2.68,-5062,59890,-8%,"-$13,555",,,,,OMED
12,,2018-04-26 18:13:41,2018-04-24,OMED,Stagg Robert,"SVP, Clinical R, D",S - Sale,$2.68,-4051,43283,-9%,"-$10,848",,,,,OMED
13,,2018-04-26 18:13:11,2018-04-24,OMED,Lewicki John A.,"Pres, CEO",S - Sale,$2.68,-4557,154806,-3%,"-$12,202",,,,,OMED
14,,2018-04-26 18:12:39,2018-04-24,OMED,Gurney Austin,See Remarks,S - Sale,$2.68,-4051,76766,-5%,"-$10,848",,,,,OMED
15,,2018-04-26 18:11:59,2018-04-24,OMED,Hager Alicia J.,"SVP, GC",S - Sale,$2.68,-4051,54596,-7%,"-$10,848",,,,,OMED
16,D,2018-02-28 16:45:06,2018-02-26,OMED,Karsen Perry A,Dir,A - Grant,$0.00,70500,80500,+705%,+$0,,,,,OMED
17,,2017-10-12 18:36:08,2017-10-10,OMED,Patel Sunil,See Remarks,S - Sale,$4.24,-1248,68336,-2%,"-$5,295",,,,,OMED
18,,2017-10-12 18:35:30,2017-10-10,OMED,Hastings Paul J,"COB, CEO",S - Sale,$4.24,-1398,401028,0%,"-$5,931",,,,,OMED
19,,2017-10-12 18:35:01,2017-10-10,OMED,Lewicki John A.,"EVP, Research, Development",S - Sale,$4.24,-1248,159363,-1%,"-$5,295",,,,,OMED
20,,2017-10-12 18:34:26,2017-10-10,OMED,Gurney Austin,See Remarks,S - Sale,$4.24,-1248,80817,-2%,"-$5,295",,,,,OMED
21,,2017-10-12 18:33:45,2017-10-10,OMED,Hager Alicia J.,"SVP, GC",S - Sale,$4.24,-1248,58647,-2%,"-$5,295",,,,,OMED
22,D,2017-10-10 19:28:48,2017-10-07,OMED,Patel Sunil,See Remarks,A - Grant,$0.00,25000,69584,+56%,+$0,,,,,OMED
23,D,2017-10-10 19:28:12,2017-10-07,OMED,Lewicki John A.,"EVP, Research, Development",A - Grant,$0.00,25000,160611,+18%,+$0,,,,,OMED
24,D,2017-10-10 19:27:32,2017-10-07,OMED,Hager Alicia J.,"SVP, GC",A - Grant,$0.00,18334,59895,+44%,+$0,,,,,OMED
25,D,2017-10-10 19:27:00,2017-10-07,OMED,Gurney Austin,See Remarks,A - Grant,$0.00,18334,82065,+29%,+$0,,,,,OMED
26,,2017-06-07 18:18:45,2017-06-05,OMED,Karsen Perry A,Dir,P - Purchase,$3.46,10000,10000,New,"+$34,588",,,,,OMED
27,,2017-05-26 17:51:44,2017-05-25,OMED,Lasersohn Jack W,Dir,P - Purchase,$3.37,34614,1685913,+2%,"+$116,639",,,,,OMED
28,M,2017-05-26 11:57:01,2017-05-24,OMED,Root Jonathan D,Dir,S - Sale,$3.71,-13880,121020,-10%,"-$51,441",,,,,OMED
29,,2017-05-25 18:33:48,2017-05-23,OMED,Lasersohn Jack W,Dir,P - Purchase,$3.55,20000,1651299,+1%,"+$71,000",,,,,OMED
30,,2017-05-22 20:16:40,2017-05-19,OMED,Root Jonathan D,Dir,S - Sale,$3.70,-7487,134900,-5%,"-$27,712",,,,,OMED
31,,2017-05-18 18:43:10,2017-05-16,OMED,Lasersohn Jack W,Dir,P - Purchase,$3.49,23507,1631299,+1%,"+$82,061",,,,,OMED
32,,2017-05-18 16:49:16,2017-05-16,OMED,Root Jonathan D,Dir,S - Sale,$3.58,-6900,142387,-5%,"-$24,714",,,,,OMED
33,D,2017-04-25 18:13:24,2017-04-23,OMED,Hoey Timothy,"SVP, Cancer Biology, Co-CSO",A - Grant,$0.00,20000,77225,+35%,+$0,7.0,0.0,,,OMED
34,D,2017-04-25 18:12:43,2017-04-23,OMED,Patel Sunil,See Remarks,A - Grant,$0.00,20000,44584,+81%,+$0,7.0,0.0,,,OMED
35,D,2017-04-25 18:12:03,2017-04-24,OMED,Hastings Paul J,"COB, CEO",A - Grant,$0.00,45000,402426,+13%,+$0,7.0,0.0,,,OMED
36,D,2017-04-25 18:11:20,2017-04-23,OMED,Lewicki John A.,"EVP, Research, Development",A - Grant,$0.00,22500,134388,+20%,+$0,7.0,0.0,,,OMED
37,D,2017-04-25 18:10:49,2017-04-23,OMED,Gurney Austin,See Remarks,A - Grant,$0.00,20000,63301,+46%,+$0,7.0,0.0,,,OMED
38,D,2017-04-25 18:09:52,2017-04-23,OMED,Hager Alicia J.,"SVP, GC",A - Grant,$0.00,20000,41561,+93%,+$0,7.0,0.0,,,OMED
39,,2017-04-05 19:56:04,2017-04-04,OMED,Lewicki John A.,"EVP, Research, Development",S - Sale,$9.06,-5754,111888,-5%,"-$52,113",3.0,-41.0,-56.0,,OMED
40,,2017-04-05 19:41:27,2017-04-04,OMED,Gurney Austin,See Remarks,S - Sale,$9.06,-5754,43301,-12%,"-$52,113",3.0,-41.0,-56.0,,OMED
41,,2017-04-05 19:40:49,2017-04-04,OMED,Patel Sunil,See Remarks,S - Sale,$9.06,-5754,24584,-19%,"-$52,113",3.0,-41.0,-56.0,,OMED
42,,2017-04-05 19:40:14,2017-04-04,OMED,Hoey Timothy,"SVP, Cancer Biology, Co-CSO",S - Sale,$9.06,-5754,57225,-9%,"-$52,113",3.0,-41.0,-56.0,,OMED
43,,2017-04-05 19:39:25,2017-04-04,OMED,Hager Alicia J.,"SVP, GC",S - Sale,$9.06,-4316,21561,-17%,"-$39,089",3.0,-41.0,-56.0,,OMED
44,,2017-04-05 19:38:27,2017-04-04,OMED,Hastings Paul J,"COB, CEO",S - Sale,$9.06,-6473,357426,-2%,"-$58,625",3.0,-41.0,-56.0,,OMED
45,D,2017-03-17 17:57:55,2017-03-15,OMED,Hager Alicia J.,"SVP, GC",M - OptEx,$3.42,6652,25877,+35%,"+$22,750",-3.0,-8.0,-59.0,,OMED
46,D,2017-03-17 17:57:55,2017-03-15,OMED,Hager Alicia J.,"SVP, GC",S - Sale+OE,$10.00,-6652,25877,-20%,"-$66,520",-3.0,-8.0,-59.0,,OMED
47,DM,2017-01-09 17:55:08,2017-01-05,OMED,Hastings Paul J,"COB, CEO",M - OptEx,$1.43,42738,362163,+13%,"+$61,115",1.0,-8.0,-9.0,,OMED
48,DM,2017-01-09 17:55:08,2017-01-05,OMED,Hastings Paul J,"COB, CEO",S - Sale+OE,$8.34,-42738,362163,-11%,"-$356,559",1.0,-8.0,-9.0,,OMED
49,D,2017-01-05 19:11:18,2017-01-03,OMED,Lewicki John A.,"EVP, Research, Development",M - OptEx,$1.43,9175,116451,+9%,"+$13,120",5.0,-2.0,-1.0,,OMED
50,D,2017-01-05 19:11:18,2017-01-03,OMED,Lewicki John A.,"EVP, Research, Development",S - Sale+OE,$7.63,-9175,116451,-7%,"-$70,045",5.0,-2.0,-1.0,,OMED
51,D,2017-01-05 19:07:31,2017-01-03,OMED,Hoey Timothy,"SVP, Cancer Biology, Co-CSO",M - OptEx,$1.43,12763,60979,+26%,"+$18,251",5.0,-2.0,-1.0,,OMED
52,D,2017-01-05 19:07:31,2017-01-03,OMED,Hoey Timothy,"SVP, Cancer Biology, Co-CSO",S - Sale+OE,$7.64,-12763,60979,-17%,"-$97,448",5.0,-2.0,-1.0,,OMED
53,D,2016-11-18 18:21:03,2016-11-16,OMED,Hoey Timothy,"SVP, Cancer Biology, Co-CSO",M - OptEx,$1.43,12500,60979,+26%,"+$17,875",-2.0,-1.0,-20.0,,OMED
54,D,2016-11-18 18:21:03,2016-11-16,OMED,Hoey Timothy,"SVP, Cancer Biology, Co-CSO",S - Sale+OE,$9.89,-12500,60979,-17%,"-$123,609",-2.0,-1.0,-20.0,,OMED
55,,2016-10-11 21:44:17,2016-10-09,OMED,Lewicki John A.,"EVP, Research, Development",A - Grant,$0.00,12500,116451,+12%,+$0,-3.0,-3.0,-11.0,-45.0,OMED
56,,2016-10-11 21:43:52,2016-10-09,OMED,Hoey Timothy,"SVP, Co-CSO",A - Grant,$0.00,12500,60979,+26%,+$0,-3.0,-3.0,-11.0,-45.0,OMED
57,,2016-10-11 21:43:25,2016-10-09,OMED,Hastings Paul J,"COB, CEO",A - Grant,$0.00,14000,362163,+4%,+$0,-3.0,-3.0,-11.0,-45.0,OMED
58,,2016-10-11 21:42:48,2016-10-09,OMED,Gurney Austin,"SVP, Co-CSO",A - Grant,$0.00,12500,47055,+36%,+$0,-3.0,-3.0,-11.0,-45.0,OMED
59,,2016-10-11 21:42:22,2016-10-09,OMED,Dupont Jakob,"SVP, Chief Medical Officer",A - Grant,$0.00,12500,34440,+57%,+$0,-3.0,-3.0,-11.0,-45.0,OMED
60,,2016-10-11 21:41:56,2016-10-09,OMED,Patel Sunil,See Remarks,A - Grant,$0.00,12500,30338,+70%,+$0,-3.0,-3.0,-11.0,-45.0,OMED
61,,2016-10-11 21:41:30,2016-10-09,OMED,Hager Alicia J.,"VP, GC",A - Grant,$0.00,12500,25877,+93%,+$0,-3.0,-3.0,-11.0,-45.0,OMED
62,D,2016-01-12 17:38:45,2016-01-11,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,2500,20642,+14%,"+$11,400",-13.0,-10.0,-47.0,-24.0,OMED
63,D,2016-01-12 17:38:45,2016-01-11,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$20.01,-2500,20642,-11%,"-$50,021",-13.0,-10.0,-47.0,-24.0,OMED
64,M,2016-01-08 19:27:27,2016-01-06,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale,$22.28,-2162,20642,-9%,"-$48,160",-15.0,-21.0,-52.0,-35.0,OMED
65,M,2016-01-08 19:26:58,2016-01-06,OMED,Gurney Austin,See Remarks,S - Sale,$22.28,-2162,33257,-6%,"-$48,160",-15.0,-21.0,-52.0,-35.0,OMED
66,M,2016-01-08 19:26:24,2016-01-06,OMED,Hoey Timothy,"SVP, Cancer Biology",S - Sale,$22.28,-2162,47181,-4%,"-$48,162",-15.0,-21.0,-52.0,-35.0,OMED
67,,2016-01-08 19:25:54,2016-01-06,OMED,Hastings Paul J,"COB, CEO",S - Sale,$22.28,-2412,346865,-1%,"-$53,731",-15.0,-21.0,-52.0,-35.0,OMED
68,M,2016-01-08 19:25:24,2016-01-06,OMED,Hager Alicia J.,"VP, GC",S - Sale,$22.28,-1623,13377,-11%,"-$36,153",-15.0,-21.0,-52.0,-35.0,OMED
69,M,2016-01-08 19:24:35,2016-01-06,OMED,Patel Sunil,See Remarks,S - Sale,$22.28,-2162,17838,-11%,"-$48,168",-15.0,-21.0,-52.0,-35.0,OMED
70,M,2016-01-08 19:24:06,2016-01-06,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale,$22.28,-2162,102653,-2%,"-$48,162",-15.0,-21.0,-52.0,-35.0,OMED
71,D,2015-12-14 17:02:24,2015-12-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,2500,22804,+12%,"+$11,400",3.0,3.0,-25.0,-39.0,OMED
72,D,2015-12-14 17:02:24,2015-12-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$20.49,-2500,22804,-10%,"-$51,231",3.0,3.0,-25.0,-39.0,OMED
73,D,2015-12-01 17:19:36,2015-11-27,OMED,Hager Alicia J.,"VP, GC",M - OptEx,$3.42,1800,15000,+14%,"+$6,156",-6.0,-4.0,4.0,-28.0,OMED
74,D,2015-12-01 17:19:36,2015-11-27,OMED,Hager Alicia J.,"VP, GC",S - Sale+OE,$23.14,-1800,15000,-11%,"-$41,654",-6.0,-4.0,4.0,-28.0,OMED
75,D,2015-11-12 18:48:50,2015-11-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,2500,22804,+12%,"+$11,400",3.0,12.0,1.0,-41.0,OMED
76,D,2015-11-12 18:48:50,2015-11-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$21.17,-2500,22804,-10%,"-$52,923",3.0,12.0,1.0,-41.0,OMED
77,D,2015-10-29 19:49:01,2015-10-27,OMED,Hager Alicia J.,"VP, GC",M - OptEx,$3.42,5400,15000,+56%,"+$18,468",-8.0,-2.0,9.0,-42.0,OMED
78,D,2015-10-29 19:49:01,2015-10-27,OMED,Hager Alicia J.,"VP, GC",S - Sale+OE,$21.00,-5400,15000,-26%,"-$113,400",-8.0,-2.0,9.0,-42.0,OMED
79,,2015-10-27 19:15:32,2015-10-26,OMED,Gurney Austin,See Remarks,S - Sale,$20.00,-14000,35419,-28%,"-$280,000",2.0,-2.0,5.0,-49.0,OMED
80,D,2015-10-27 19:14:21,2015-10-26,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,5000,22804,+28%,"+$22,800",2.0,-2.0,5.0,-49.0,OMED
81,D,2015-10-27 19:14:21,2015-10-26,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$20.00,-5000,22804,-18%,"-$100,000",2.0,-2.0,5.0,-49.0,OMED
82,,2015-10-01 19:39:48,2015-09-30,OMED,Lasersohn Jack W,Dir,P - Purchase,$16.01,11210,2299267,0%,"+$179,512",13.0,9.0,29.0,-40.0,OMED
83,M,2015-09-30 19:54:03,2015-09-28,OMED,Lasersohn Jack W,Dir,P - Purchase,$14.60,13140,2288057,+1%,"+$191,784",2.0,10.0,38.0,-44.0,OMED
84,D,2015-08-12 19:14:08,2015-08-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,2500,22377,+13%,"+$11,400",-1.0,4.0,-10.0,-58.0,OMED
85,D,2015-08-12 19:14:08,2015-08-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$22.25,-2500,22377,-10%,"-$55,622",-1.0,4.0,-10.0,-58.0,OMED
86,M,2015-07-31 16:21:58,2015-07-29,OMED,Gurney Austin,See Remarks,S - Sale,$20.88,-14000,49419,-22%,"-$292,359",-3.0,-6.0,-12.0,-63.0,OMED
87,D,2015-07-29 16:57:57,2015-07-28,OMED,Hager Alicia J.,"VP, GC",M - OptEx,$3.42,1800,15000,+14%,"+$6,156",5.0,10.0,-7.0,-53.0,OMED
88,D,2015-07-29 16:57:57,2015-07-28,OMED,Hager Alicia J.,"VP, GC",S - Sale+OE,$21.00,-1800,15000,-11%,"-$37,800",5.0,10.0,-7.0,-53.0,OMED
89,D,2015-07-13 17:28:53,2015-07-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,2500,22377,+13%,"+$11,400",3.0,2.0,6.0,-3.0,OMED
90,D,2015-07-13 17:28:53,2015-07-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$20.13,-2500,22377,-10%,"-$50,325",3.0,2.0,6.0,-3.0,OMED
91,D,2015-07-07 17:06:32,2015-07-06,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,2500,22377,+13%,"+$11,400",-7.0,-1.0,7.0,3.0,OMED
92,D,2015-07-07 17:06:32,2015-07-06,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$21.22,-2500,22377,-10%,"-$53,050",-7.0,-1.0,7.0,3.0,OMED
93,D,2015-06-30 17:17:45,2015-06-29,OMED,Hager Alicia J.,"VP, GC",M - OptEx,$3.42,1800,15000,+14%,"+$6,156",-4.0,-5.0,-8.0,-2.0,OMED
94,D,2015-06-30 17:17:45,2015-06-29,OMED,Hager Alicia J.,"VP, GC",S - Sale+OE,$22.67,-1800,15000,-11%,"-$40,798",-4.0,-5.0,-8.0,-2.0,OMED
95,D,2015-06-24 16:12:42,2015-06-22,OMED,Hoey Timothy,"SVP, Cancer Biology",M - OptEx,$1.43,5000,49343,+11%,"+$7,150",-4.0,-8.0,-12.0,-13.0,OMED
96,D,2015-06-24 16:12:42,2015-06-22,OMED,Hoey Timothy,"SVP, Cancer Biology",S - Sale+OE,$26.07,-5000,49343,-9%,"-$130,337",-4.0,-8.0,-12.0,-13.0,OMED
97,DM,2015-06-17 17:49:03,2015-06-15,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",M - OptEx,$1.77,17000,104815,+19%,"+$30,077",2.0,0.0,-16.0,-22.0,OMED
98,DM,2015-06-17 17:49:03,2015-06-15,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale+OE,$25.07,-17000,104815,-14%,"-$426,125",2.0,0.0,-16.0,-22.0,OMED
99,D,2015-05-28 19:05:37,2015-05-27,OMED,Hager Alicia J.,"VP, GC",M - OptEx,$3.42,1800,15000,+14%,"+$6,156",3.0,2.0,-2.0,-7.0,OMED
100,D,2015-05-28 19:05:37,2015-05-27,OMED,Hager Alicia J.,"VP, GC",S - Sale+OE,$23.07,-1800,15000,-11%,"-$41,527",3.0,2.0,-2.0,-7.0,OMED
101,,2015-05-20 20:12:25,2015-05-18,OMED,Gurney Austin,See Remarks,S - Sale,$22.48,-4000,63419,-6%,"-$89,900",0.0,3.0,13.0,-11.0,OMED
102,D,2015-04-29 17:44:36,2015-04-27,OMED,Hager Alicia J.,"VP, GC",M - OptEx,$3.42,1800,15000,+14%,"+$6,156",-7.0,-11.0,-6.0,-22.0,OMED
103,D,2015-04-29 17:44:36,2015-04-27,OMED,Hager Alicia J.,"VP, GC",S - Sale+OE,$25.65,-1800,15000,-11%,"-$46,172",-7.0,-11.0,-6.0,-22.0,OMED
104,D,2015-04-29 17:43:41,2015-04-27,OMED,Hoey Timothy,"SVP, Cancer Biology",M - OptEx,$1.43,5000,49343,+11%,"+$7,150",-7.0,-11.0,-6.0,-22.0,OMED
105,D,2015-04-29 17:43:41,2015-04-27,OMED,Hoey Timothy,"SVP, Cancer Biology",S - Sale+OE,$25.65,-6887,49343,-12%,"-$176,645",-7.0,-11.0,-6.0,-22.0,OMED
106,,2015-04-20 19:18:25,2015-04-17,OMED,Gurney Austin,See Remarks,S - Sale,$25.51,-4000,67419,-6%,"-$102,049",-4.0,-4.0,-16.0,-31.0,OMED
107,D,2015-04-14 15:00:58,2015-04-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,1500,22377,+7%,"+$6,840",2.0,2.0,-13.0,-30.0,OMED
108,D,2015-04-14 15:00:58,2015-04-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$26.51,-1500,22377,-6%,"-$39,765",2.0,2.0,-13.0,-30.0,OMED
109,DM,2015-04-03 15:42:51,2015-04-01,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",M - OptEx,$1.43,17000,104815,+19%,"+$24,310",-2.0,3.0,-7.0,-34.0,OMED
110,DM,2015-04-03 15:42:51,2015-04-01,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale+OE,$25.28,-17000,104815,-14%,"-$429,709",-2.0,3.0,-7.0,-34.0,OMED
111,DM,2015-03-23 20:31:55,2015-03-19,OMED,Patel Sunil,See Remarks,M - OptEx,$3.42,18000,20000,+900%,"+$61,560",-3.0,-8.0,-8.0,-34.0,OMED
112,DM,2015-03-23 20:31:55,2015-03-19,OMED,Patel Sunil,See Remarks,S - Sale+OE,$27.76,-18000,20000,-47%,"-$499,730",-3.0,-8.0,-8.0,-34.0,OMED
113,,2015-03-19 17:43:31,2015-03-17,OMED,Gurney Austin,See Remarks,S - Sale,$27.37,-4000,71419,-5%,"-$109,470",3.0,-6.0,-6.0,-31.0,OMED
114,D,2015-03-12 20:00:23,2015-03-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,1500,21620,+7%,"+$6,840",-3.0,-3.0,-7.0,-35.0,OMED
115,D,2015-03-12 20:00:23,2015-03-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$27.17,-1500,21620,-6%,"-$40,754",-3.0,-3.0,-7.0,-35.0,OMED
116,,2015-02-19 19:39:11,2015-02-17,OMED,Gurney Austin,See Remarks,S - Sale,$26.37,-4000,74134,-5%,"-$105,493",0.0,1.0,0.0,-19.0,OMED
117,D,2015-02-12 17:34:56,2015-02-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,1500,21620,+7%,"+$6,840",1.0,5.0,6.0,-19.0,OMED
118,D,2015-02-12 17:34:56,2015-02-10,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$24.23,-1500,21620,-6%,"-$36,351",1.0,5.0,6.0,-19.0,OMED
119,D,2015-02-09 17:45:28,2015-02-05,OMED,Hoey Timothy,"SVP, Cancer Biology",M - OptEx,$1.43,7500,49945,+18%,"+$10,725",1.0,7.0,13.0,-10.0,OMED
120,D,2015-02-09 17:45:28,2015-02-05,OMED,Hoey Timothy,"SVP, Cancer Biology",S - Sale+OE,$22.83,-7500,49945,-13%,"-$171,239",1.0,7.0,13.0,-10.0,OMED
121,D,2015-02-04 13:34:47,2015-02-02,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",M - OptEx,$1.43,4000,103530,+4%,"+$5,720",-2.0,9.0,22.0,1.0,OMED
122,D,2015-02-04 13:34:47,2015-02-02,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale+OE,$22.49,-4000,103530,-4%,"-$89,951",-2.0,9.0,22.0,1.0,OMED
123,,2015-01-21 21:36:21,2015-01-20,OMED,Gurney Austin,See Remarks,S - Sale,$22.87,-4000,78134,-5%,"-$91,476",1.0,3.0,20.0,-5.0,OMED
124,D,2015-01-14 17:45:45,2015-01-12,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,1500,21620,+7%,"+$6,840",-1.0,-3.0,11.0,-7.0,OMED
125,D,2015-01-14 17:45:45,2015-01-12,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$25.89,-1500,21620,-6%,"-$38,836",-1.0,-3.0,11.0,-7.0,OMED
126,D,2015-01-07 16:03:07,2015-01-05,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,7500,21620,+53%,"+$34,200",0.0,-11.0,-8.0,-24.0,OMED
127,D,2015-01-07 16:03:07,2015-01-05,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$23.00,-7500,21620,-26%,"-$172,500",0.0,-11.0,-8.0,-24.0,OMED
128,D,2015-01-05 20:24:06,2015-01-02,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",M - OptEx,$1.43,4000,103530,+4%,"+$5,720",1.0,10.0,-6.0,-11.0,OMED
129,D,2015-01-05 20:24:06,2015-01-02,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale+OE,$22.10,-4000,103530,-4%,"-$88,408",1.0,10.0,-6.0,-11.0,OMED
130,,2015-01-02 15:33:15,2014-12-31,OMED,Pollard-Knight Denise,Dir,S - Sale,$21.66,-3799,1943509,0%,"-$82,300",4.0,18.0,5.0,-2.0,OMED
131,M,2014-12-30 19:37:27,2014-12-26,OMED,Pollard-Knight Denise,Dir,S - Sale,$21.63,-17607,1947308,-1%,"-$380,850",2.0,13.0,8.0,5.0,OMED
132,,2014-12-23 17:10:41,2014-12-19,OMED,Pollard-Knight Denise,Dir,S - Sale,$21.71,-20654,1964915,-1%,"-$448,310",4.0,6.0,11.0,21.0,OMED
133,,2014-12-19 14:01:33,2014-12-17,OMED,Gurney Austin,See Remarks,S - Sale,$20.00,-4000,82134,-5%,"-$80,000",1.0,1.0,6.0,25.0,OMED
134,,2014-12-19 13:36:51,2014-12-18,OMED,Root Jonathan D,Dir,S - Sale,$21.05,-13052,28267,-32%,"-$274,784",1.0,1.0,6.0,25.0,OMED
135,M,2014-12-10 19:23:48,2014-12-08,OMED,Pollard-Knight Denise,Dir,S - Sale,$21.78,-32940,1985569,-2%,"-$717,293",-3.0,-10.0,24.0,20.0,OMED
136,,2014-12-05 18:59:01,2014-12-05,OMED,Pollard-Knight Denise,Dir,S - Sale,$21.60,-25000,2018509,-1%,"-$539,951",1.0,-5.0,14.0,16.0,OMED
137,D,2014-12-03 15:23:52,2014-12-01,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",M - OptEx,$1.43,4000,103530,+4%,"+$5,720",0.0,5.0,8.0,17.0,OMED
138,D,2014-12-03 15:23:52,2014-12-01,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale+OE,$21.19,-4000,103530,-4%,"-$84,752",0.0,5.0,8.0,17.0,OMED
139,,2014-11-19 16:09:22,2014-11-17,OMED,Gurney Austin,See Remarks,S - Sale,$20.16,-4000,86134,-4%,"-$80,659",3.0,4.0,0.0,9.0,OMED
140,D,2014-11-07 13:42:20,2014-11-05,OMED,Hoey Timothy,"SVP, Cancer Biology",M - OptEx,$1.43,2500,49945,+5%,"+$3,575",0.0,3.0,6.0,16.0,OMED
141,D,2014-11-07 13:42:20,2014-11-05,OMED,Hoey Timothy,"SVP, Cancer Biology",S - Sale+OE,$19.51,-2500,49945,-5%,"-$48,766",0.0,3.0,6.0,16.0,OMED
142,DM,2014-11-05 19:28:59,2014-09-08,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",G - Gift,$0.00,-1204,103530,+1%,-$0,3.0,9.0,7.0,17.0,OMED
143,D,2014-11-05 19:28:59,2014-11-03,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",M - OptEx,$1.43,4000,103530,+4%,"+$5,720",3.0,9.0,7.0,17.0,OMED
144,D,2014-11-05 19:28:59,2014-11-03,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale+OE,$20.45,-4000,103530,-4%,"-$81,818",3.0,9.0,7.0,17.0,OMED
145,DM,2014-10-30 19:27:30,2014-10-28,OMED,Hastings Paul J,"COB, CEO",M - OptEx,$1.43,16769,348071,+5%,"+$23,980",-6.0,-11.0,-1.0,7.0,OMED
146,DM,2014-10-30 19:27:30,2014-10-28,OMED,Hastings Paul J,"COB, CEO",S - Sale+OE,$21.99,-16769,348071,-5%,"-$368,742",-6.0,-11.0,-1.0,7.0,OMED
147,,2014-10-20 15:39:17,2014-10-17,OMED,Gurney Austin,See Remarks,S - Sale,$20.07,-4000,90134,-4%,"-$80,280",-1.0,9.0,3.0,34.0,OMED
148,,2014-10-03 14:35:56,2014-10-02,OMED,Gurney Austin,See Remarks,S - Sale,$20.00,-4000,94134,-4%,"-$80,000",-4.0,-11.0,2.0,23.0,OMED
149,D,2014-10-03 14:35:21,2014-10-02,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",M - OptEx,$1.43,5809,103530,+6%,"+$8,307",-4.0,-11.0,2.0,23.0,OMED
150,D,2014-10-03 14:35:21,2014-10-02,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale+OE,$20.00,-5809,103530,-5%,"-$116,180",-4.0,-11.0,2.0,23.0,OMED
151,M,2014-09-05 18:07:53,2014-09-03,OMED,Lasersohn Jack W,Dir,P - Purchase,$18.35,3170,2497777,0%,"+$58,174",2.0,-2.0,5.0,50.0,OMED
152,D,2014-09-03 15:03:15,2014-09-02,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",M - OptEx,$1.43,2191,103530,+2%,"+$3,133",-4.0,-8.0,1.0,37.0,OMED
153,D,2014-09-03 15:03:15,2014-09-02,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale+OE,$20.01,-2191,103530,-2%,"-$43,831",-4.0,-8.0,1.0,37.0,OMED
154,,2014-08-25 17:10:06,2014-08-22,OMED,Gurney Austin,See Remarks,S - Sale,$20.00,-4000,97532,-4%,"-$80,000",2.0,4.0,-8.0,38.0,OMED
155,M,2014-08-21 19:47:50,2014-08-19,OMED,Pakianathan Deepika,Dir,P - Purchase,$18.98,80203,2010542,+4%,"+$1,521,872",5.0,3.0,-10.0,42.0,OMED
156,,2014-08-19 16:51:31,2014-08-15,OMED,Lasersohn Jack W,Dir,P - Purchase,$17.00,1045,2494607,0%,"+$17,765",0.0,3.0,-1.0,42.0,OMED
157,D,2014-08-07 16:06:57,2014-08-05,OMED,Hoey Timothy,"SVP, Cancer Biology",M - OptEx,$1.43,2500,49343,+5%,"+$3,575",-4.0,-15.0,-11.0,14.0,OMED
158,D,2014-08-07 16:06:57,2014-08-05,OMED,Hoey Timothy,"SVP, Cancer Biology",S - Sale+OE,$21.66,-2500,49343,-5%,"-$54,156",-4.0,-15.0,-11.0,14.0,OMED
159,D,2014-08-04 17:38:16,2014-08-01,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",M - OptEx,$1.43,4000,102928,+4%,"+$5,720",-2.0,-9.0,-12.0,4.0,OMED
160,D,2014-08-04 17:38:16,2014-08-01,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale+OE,$20.98,-4000,102928,-4%,"-$83,912",-2.0,-9.0,-12.0,4.0,OMED
161,DM,2014-07-30 19:53:46,2014-07-28,OMED,Hastings Paul J,"COB, CEO",M - OptEx,$1.43,16770,347340,+5%,"+$23,981",-5.0,-6.0,-14.0,0.0,OMED
162,DM,2014-07-30 19:53:46,2014-07-28,OMED,Hastings Paul J,"COB, CEO",S - Sale+OE,$22.11,-16770,347340,-5%,"-$370,738",-5.0,-6.0,-14.0,0.0,OMED
163,D,2014-07-25 18:24:56,2014-07-23,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,1500,20896,+8%,"+$6,840",-4.0,-5.0,-12.0,-2.0,OMED
164,D,2014-07-25 18:24:56,2014-07-23,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$23.00,-1500,20896,-7%,"-$34,500",-4.0,-5.0,-12.0,-2.0,OMED
165,,2014-07-18 20:16:56,2014-07-17,OMED,Gurney Austin,See Remarks,S - Sale,$20.46,-4000,101532,-4%,"-$81,853",-2.0,7.0,-20.0,5.0,OMED
166,D,2014-07-03 13:17:57,2014-07-01,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",M - OptEx,$1.43,4000,102928,+4%,"+$5,720",-1.0,-11.0,-12.0,-9.0,OMED
167,D,2014-07-03 13:17:57,2014-07-01,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale+OE,$23.86,-4000,102928,-4%,"-$95,434",-1.0,-11.0,-12.0,-9.0,OMED
168,A,2014-07-03 13:16:56,2014-06-16,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale,$24.59,-4000,20000,-17%,"-$98,348",-1.0,-11.0,-12.0,-9.0,OMED
169,,2014-07-02 13:40:51,2014-06-30,OMED,Pollard-Knight Denise,Dir,S - Sale,$23.59,-11485,2043509,-1%,"-$270,919",-1.0,-14.0,-10.0,-11.0,OMED
170,D,2014-06-30 19:51:11,2014-06-26,OMED,Dupont Jakob,"SVP, Chief Medical Officer",M - OptEx,$4.56,1500,20896,+8%,"+$6,840",3.0,-5.0,-2.0,-8.0,OMED
171,D,2014-06-30 19:51:11,2014-06-26,OMED,Dupont Jakob,"SVP, Chief Medical Officer",S - Sale+OE,$23.00,-1500,20896,-7%,"-$34,503",3.0,-5.0,-2.0,-8.0,OMED
172,,2014-06-27 13:56:29,2014-06-25,OMED,Pollard-Knight Denise,Dir,S - Sale,$23.56,-3252,2054994,0%,"-$76,624",-4.0,1.0,-6.0,-10.0,OMED
173,M,2014-06-25 17:25:46,2014-06-23,OMED,Pollard-Knight Denise,Dir,S - Sale,$24.08,-64561,2058246,-3%,"-$1,554,749",0.0,3.0,0.0,-8.0,OMED
174,,2014-06-18 19:50:11,2014-06-17,OMED,Gurney Austin,See Remarks,S - Sale,$24.99,-4000,105532,-4%,"-$99,965",-5.0,-12.0,-22.0,-30.0,OMED
175,D,2014-06-17 19:55:05,2014-06-16,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",M - OptEx,$1.43,4000,102928,+4%,"+$5,720",3.0,-8.0,-18.0,-21.0,OMED
176,D,2014-06-17 19:55:05,2014-06-16,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",S - Sale+OE,$24.59,-4000,102928,-4%,"-$98,348",3.0,-8.0,-18.0,-21.0,OMED
177,M,2014-06-11 17:29:04,2014-06-09,OMED,Root Jonathan D,"Dir, 10%",S - Sale,$24.57,-13052,33067,-28%,"-$320,668",4.0,5.0,-11.0,-9.0,OMED
178,M,2014-06-11 17:27:44,2014-06-09,OMED,Presidio Management Group VIII L L C,10%,S - Sale,$24.57,-13052,33067,-28%,"-$320,668",4.0,5.0,-11.0,-9.0,OMED
179,,2014-05-19 17:59:58,2014-05-15,OMED,Presidio Management Group VIII L L C,10%,S - Sale,$22.51,-28956,0,-100%,"-$651,800",-4.0,-1.0,11.0,-7.0,OMED
180,,2014-05-13 19:41:30,2014-05-12,OMED,Presidio Management Group VIII L L C,10%,S - Sale,$21.99,-46327,3040860,-2%,"-$1,018,557",1.0,1.0,7.0,-10.0,OMED
181,D,2014-05-07 19:45:28,2014-05-05,OMED,Hoey Timothy,"SVP, Cancer Biology",M - OptEx,$1.43,2500,49343,+5%,"+$3,575",-9.0,-10.0,-6.0,-17.0,OMED
182,D,2014-05-07 19:45:28,2014-05-05,OMED,Hoey Timothy,"SVP, Cancer Biology",S - Sale+OE,$26.41,-2500,49343,-5%,"-$66,019",-9.0,-10.0,-6.0,-17.0,OMED
183,,2014-03-27 17:26:18,2014-03-25,OMED,Dupont Jakob,"SVP, Chief Medical Officer",A - Grant,$0.00,20000,20896,>999%,+$0,-2.0,7.0,-14.0,-37.0,OMED
184,,2014-03-27 17:25:50,2014-03-25,OMED,Gurney Austin,See Remarks,A - Grant,$0.00,20000,109532,+22%,+$0,-2.0,7.0,-14.0,-37.0,OMED
185,,2014-03-27 17:25:17,2014-03-25,OMED,Hager Alicia J.,"VP, GC",A - Grant,$0.00,15000,15000,New,+$0,-2.0,7.0,-14.0,-37.0,OMED
186,,2014-03-27 17:24:49,2014-03-25,OMED,Hastings Paul J,"COB, CEO",A - Grant,$0.00,22500,347340,+7%,+$0,-2.0,7.0,-14.0,-37.0,OMED
187,,2014-03-27 17:24:19,2014-03-25,OMED,Hoey Timothy,"SVP, Cancer Biology",A - Grant,$0.00,20000,49343,+68%,+$0,-2.0,7.0,-14.0,-37.0,OMED
188,,2014-03-27 17:23:51,2014-03-25,OMED,Patel Sunil,"SVP, Chief Business Officer",A - Grant,$0.00,20000,20000,New,+$0,-2.0,7.0,-14.0,-37.0,OMED
189,,2014-03-27 17:23:13,2014-03-25,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",A - Grant,$0.00,20000,185856,+12%,+$0,-2.0,7.0,-14.0,-37.0,OMED
190,,2014-03-27 17:23:13,2014-03-20,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",G - Gift,$0.00,-3584,185856,+2%,-$0,-2.0,7.0,-14.0,-37.0,OMED
191,,2014-03-12 20:49:58,2014-03-06,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",G - Gift,$0.00,-162272,82928,-205%,-$0,-5.0,2.0,-17.0,-49.0,OMED
192,,2014-03-07 17:46:06,2014-03-05,OMED,Hoey Timothy,"SVP, Cancer Biology",S - Sale,$35.81,-1792,29343,-6%,"-$64,180",-3.0,-6.0,-25.0,-49.0,OMED
193,D,2014-02-07 18:19:13,2014-02-05,OMED,Hoey Timothy,"SVP, Cancer Biology",M - OptEx,$1.43,5000,29343,+21%,"+$7,150",6.0,20.0,14.0,-30.0,OMED
194,D,2014-02-07 18:19:13,2014-02-05,OMED,Hoey Timothy,"SVP, Cancer Biology",S - Sale+OE,$30.10,-5000,29343,-15%,"-$150,512",6.0,20.0,14.0,-30.0,OMED
195,D,2013-07-23 19:13:10,2013-07-23,OMED,Glaxosmithkline Plc,10%,C - Converted deriv,$0.00,2607546,2607546,-50%,$0,-12.0,-21.0,-37.0,40.0,OMED
196,D,2013-07-23 19:12:58,2013-07-23,OMED,Morgenthaler Partners VII LP,10%,C - Converted deriv,$0.00,2439083,2509671,-49%,$0,-12.0,-21.0,-37.0,40.0,OMED
197,D,2013-07-23 19:12:58,2013-07-23,OMED,Morgenthaler Partners VII LP,10%,P - Purchase,$17.00,70588,2509671,+3%,"+$1,199,996",-12.0,-21.0,-37.0,40.0,OMED
198,D,2013-07-23 19:12:10,2013-07-23,OMED,Vertical Group LP,10%,C - Converted deriv,$0.00,2490682,803694,-76%,$0,-12.0,-21.0,-37.0,40.0,OMED
199,D,2013-07-23 19:11:38,2013-07-23,OMED,"Lvp Gp I, LLC",10%,C - Converted deriv,$0.00,2664007,2796101,-49%,$0,-12.0,-21.0,-37.0,40.0,OMED
200,D,2013-07-23 19:11:38,2013-07-23,OMED,"Lvp Gp I, LLC",10%,P - Purchase,$17.00,88235,2796101,+3%,"+$1,499,995",-12.0,-21.0,-37.0,40.0,OMED
201,D,2013-07-23 19:11:00,2013-07-23,OMED,Presidio Management Group VIII L L C,10%,C - Converted deriv,$0.00,3837214,3996037,-49%,$0,-12.0,-21.0,-37.0,40.0,OMED
202,D,2013-07-23 19:11:00,2013-07-23,OMED,Presidio Management Group VIII L L C,10%,P - Purchase,$17.00,158823,3996037,+4%,"+$2,699,991",-12.0,-21.0,-37.0,40.0,OMED
203,D,2013-07-23 19:10:15,2013-07-23,OMED,Presidio Management Group VIII L L C,10%,C - Converted deriv,$0.00,3837214,3996037,-49%,$0,-12.0,-21.0,-37.0,40.0,OMED
204,D,2013-07-23 19:10:15,2013-07-23,OMED,Presidio Management Group VIII L L C,10%,P - Purchase,$17.00,158823,3996037,+4%,"+$2,699,991",-12.0,-21.0,-37.0,40.0,OMED
205,D,2013-07-23 19:09:35,2013-07-23,OMED,Woody James N.,"Dir, 10%",C - Converted deriv,$0.00,2672954,2783118,-49%,$0,-12.0,-21.0,-37.0,40.0,OMED
206,D,2013-07-23 19:09:35,2013-07-23,OMED,Woody James N.,"Dir, 10%",P - Purchase,$17.00,88235,2783118,+3%,"+$1,499,995",-12.0,-21.0,-37.0,40.0,OMED
207,D,2013-07-23 19:09:09,2013-07-23,OMED,Root Jonathan D,"Dir, 10%",C - Converted deriv,$0.00,3837214,3996037,-49%,$0,-12.0,-21.0,-37.0,40.0,OMED
208,D,2013-07-23 19:09:09,2013-07-23,OMED,Root Jonathan D,"Dir, 10%",P - Purchase,$17.00,158823,3996037,+4%,"+$2,699,991",-12.0,-21.0,-37.0,40.0,OMED
209,D,2013-07-23 19:08:32,2013-07-23,OMED,Broderick James W.,Dir,C - Converted deriv,$0.00,2439083,2509671,-49%,$0,-12.0,-21.0,-37.0,40.0,OMED
210,D,2013-07-23 19:08:32,2013-07-23,OMED,Broderick James W.,Dir,P - Purchase,$17.00,70588,2509671,+3%,"+$1,199,996",-12.0,-21.0,-37.0,40.0,OMED
211,D,2013-07-23 19:08:19,2013-07-23,OMED,Lasersohn Jack W,Dir,C - Converted deriv,$0.00,2490682,803694,-76%,$0,-12.0,-21.0,-37.0,40.0,OMED
212,D,2013-07-23 19:08:03,2013-07-23,OMED,Gould Terry P,Dir,C - Converted deriv,$0.00,1234703,1234703,-50%,$0,-12.0,-21.0,-37.0,40.0,OMED
213,D,2013-07-23 19:07:50,2013-07-23,OMED,Pakianathan Deepika,Dir,C - Converted deriv,$0.00,1547986,1930339,-45%,$0,-12.0,-21.0,-37.0,40.0,OMED
214,D,2013-07-23 19:07:50,2013-07-23,OMED,Pakianathan Deepika,Dir,P - Purchase,$17.00,382353,1930339,+25%,"+$6,500,001",-12.0,-21.0,-37.0,40.0,OMED
215,D,2013-07-23 19:07:37,2013-07-23,OMED,Pollard-Knight Denise,Dir,C - Converted deriv,$0.00,2063983,2122807,-49%,$0,-12.0,-21.0,-37.0,40.0,OMED
216,D,2013-07-23 19:07:37,2013-07-23,OMED,Pollard-Knight Denise,Dir,P - Purchase,$17.00,58824,2122807,+3%,"+$1,000,008",-12.0,-21.0,-37.0,40.0,OMED
217,D,2013-07-23 19:07:27,2013-07-23,OMED,Hastings Paul J,"Pres, CEO",C - Converted deriv,$0.00,40394,323765,-11%,$0,-12.0,-21.0,-37.0,40.0,OMED
218,D,2013-07-23 19:07:15,2013-07-23,OMED,Gurney Austin,See Remarks,C - Converted deriv,$0.00,11425,87740,-12%,$0,-12.0,-21.0,-37.0,40.0,OMED
219,D,2013-07-23 19:07:05,2013-07-23,OMED,Hoey Timothy,"SVP, Cancer Biology",C - Converted deriv,$0.00,8291,29343,-22%,$0,-12.0,-21.0,-37.0,40.0,OMED
220,D,2013-07-23 19:06:53,2013-07-23,OMED,Waddill William D.,"SVP, CFO",C - Converted deriv,$0.00,5159,29758,-15%,$0,-12.0,-21.0,-37.0,40.0,OMED
221,D,2013-07-23 19:06:42,2013-07-23,OMED,Lewicki John A.,"EVP, Chief Scientific Officer",C - Converted deriv,$0.00,8291,81136,-9%,$0,-12.0,-21.0,-37.0,40.0,OMED
